Amy Nguyen
Optometrist · Orange, CANPI 1538651948
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,749 of the $14,900 with a category attached, or 85.6%. It is spread thinly across 28 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $5,831 and has fallen 94.6% since, to $314 in 2025. Among optometrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 464 payments — averaging $32.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerie Pharmaceuticals, Inc.$2K
- Rxsight Inc$2K
- Sight Sciences, Inc.$1K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$1K
- Alcon$1K
- Oyster Point Pharma, Inc.$824
- plus $6K from 22 others
What the payments were for
- Consulting fees$2,00013%
- Food & beverage$12,74986%
- Education$300%
- Gifts$1211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerie Pharmaceuticals, Inc. | 102 | $2,161 |
| Rxsight Inc | 2 | $1,621 |
| Sight Sciences, Inc. | 39 | $1,295 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 74 | $1,289 |
| Alcon | 42 | $1,249 |
| Oyster Point Pharma, Inc. | 10 | $824 |
| Dompe US, Inc. | 17 | $749 |
| Glaukos Corporation | 4 | $725 |
| Sun Pharmaceutical Industries Inc. | 22 | $675 |
| AbbVie(2 entities) | 28 | $615 |
| Kala Pharmaceuticals, Inc. | 25 | $589 |
| Bausch & Lomb Americas Inc. | 15 | $489 |
| Mallinckrodt Hospital Products Inc. | 19 | $438 |
| Novartis | 23 | $407 |
| Alcon Research LLC | 9 | $405 |
| Shire North American Group Inc | 6 | $241 |
| Ocular Therapeutix, Inc. | 5 | $202 |
| Eyevance Pharmaceuticals LLC | 9 | $180 |
| Astellas Pharma US Inc | 1 | $134 |
| Carl Zeiss Meditec USA, Inc. | 1 | $126 |
| Apellis Pharmaceuticals, Inc. | 1 | $121 |
| Optovue, Inc. | 1 | $71 |
| Beaver-visitec International, Inc. | 2 | $70 |
| Coopervision Inc. | 2 | $67 |
| Carl Zeiss Meditec, Inc. | 1 | $58 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $49 |
| Johnson & Johnson Vision Care, Inc. | 1 | $32 |
| Biotissue Holdings Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$1,621
- Rhopressa$847
- Rocklatan$847
- OMNI(R) SURGICAL SYSTEM (US)$472
- Oxervate$455
- TYRVAYA$436
- DEXTENZA$375
- CEQUA$342
- EYSUVIS$246
- Izervay$134
- Clareon$131
- iStent inject Trabecular Micro-Bypass Stent System$131
- VisuMax$126
- ULTRA MULTIFOCAL TORIC$125
- ReSure Sealant$125
- DAILIES TOTAL1$125
- TearCare SmartLid$122
- TEARCARE(TM) (2.2) SYSTEM KIT$122
- Syfovre$121
- XIIDRA$121
How this compares
$14,900 in reported general payments places this provider in the 95th percentile of 6,778 optometrist providers in California.
Other optometrist in Orange
- Allen AustinOrange$62K
- Steve YoelinNewport Beach$4.1M
- Matthew GellerSpring Valley$3.5M
- Melissa EricksonDavis$522K
- Omid KhodaiLake Forest$499K
- Jason TuSan Diego$351K
- Scott SchachterPismo Beach$312K
- Alicia LauSan Diego$300K
- Vin DangBakersfield$284K
- Steven FerrucciSepulveda$272K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.